Cellectar Biosciences, Inc. (CLRB)

USD 0.25

(-5.11%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 192.37 Thousand 238.86 Thousand 227.63 Thousand 207.92 Thousand 189.36 Thousand 82.26 Thousand
Gross Profit -192.37 Thousand -238.86 Thousand -227.63 Thousand -207.92 Thousand -189.36 Thousand -82.26 Thousand
Operating Expenses 38.96 Million 28.81 Million 24.13 Million 15.29 Million 14.17 Million 11.65 Million
Selling, General and Administrative Expenses 10.74 Million 9.59 Million 6.54 Million 5.14 Million 5.18 Million 4.82 Million
Research and Development Expenses 28.21 Million 19.21 Million 17.58 Million 10.14 Million 8.99 Million 6.83 Million
Other Expenses - - 6634.00 - - -
Cost and Expenses 38.96 Million 28.81 Million 24.13 Million 15.29 Million 14.17 Million 11.65 Million
Operating Income -38.96 Million -28.81 Million -24.13 Million -15.29 Million -14.17 Million -13.33 Million
Interest Expense - - - - - 29.68 Thousand
Income Tax Expense -60 Thousand -60 Thousand -152.19 Thousand -337.63 Thousand -218.51 Thousand -1.55 Million
Earnings before Tax -38.04 Million -28.66 Million -24.12 Million -15.09 Million -14.09 Million -13.23 Million
Net Income -37.98 Million -28.6 Million -23.97 Million -14.75 Million -13.87 Million -13.23 Million
Earnings Per Share Basic -3.11 -4.05 -4.32 -7.45 -18.08 -44.70
Earnings Per Share Diluted -3.11 -4.05 -4.32 -7.45 -18.08 -44.70
Weighted Average Shares Outstanding 12.22 Million 7.05 Million 5.55 Million 1.98 Million 767.5 Thousand 296.19 Thousand
Weighted Average Shares Outstanding (Diluted) 12.22 Million 7.05 Million 5.55 Million 1.98 Million 767.5 Thousand 296.19 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -38.76 Million -28.66 Million -23.98 Million -15.14 Million -13.9 Million -13.15 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts